Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Emerging Approaches in Crohn's Disease
Details
The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management.
Autorentext
Dalia Medhat, professor of medical biochemistry at the National Research Centre-Egypt, is an expert in medical research and translational science. Her work spans cancer biology, stem cell therapy, nanomedicine, and using natural compounds to treat diabetes, neurodegenerative diseases, and liver disorders.
Klappentext
The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09786209048579
- Sprache Englisch
- Genre Biology
- Größe H220mm x B150mm
- Jahr 2025
- EAN 9786209048579
- Format Kartonierter Einband
- ISBN 978-620-9-04857-9
- Titel Emerging Approaches in Crohn's Disease
- Autor Dalia Medhat
- Untertitel Crohn's Disease: Pathogenesis and Prognostic Biomarkers with Precision Therapeutics.DE
- Herausgeber LAP LAMBERT Academic Publishing
- Anzahl Seiten 80